Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
PROteolysis TArgeting Chimeras (PROTACs) offer a therapeutic modality for protein target engagement, exploiting the ubiquitin–proteasome system to achieve precise degradation of a protein of interest. Recent advancements in understanding the structural biology of the CRL4A E3 ligase complex, particu...
Saved in:
| Main Authors: | Serena Rosignoli, Sara Giordani, Maddalena Pacelli, Giulia Guarguaglini, Alessandro Paiardini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/2/206 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PROTAC<sup>®</sup> technology and potential for its application in infection control
by: M. A. Zakharova, et al.
Published: (2024-07-01) -
Chemical knockdown of Keap1 and homoPROTAC-ing allergic rhinitis
by: Jianyu Yan, et al.
Published: (2025-08-01) -
FDA-approved kinase inhibitors in PROTAC design, development and synthesis
by: Kacper Kossakowski, et al.
Published: (2025-12-01) -
Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
by: Bikash Adhikari, et al.
Published: (2024-12-01) -
Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities
by: Muhammad Shahzad Ali, et al.
Published: (2025-07-01)